Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription


1 Acta Psychiatr Scand
1 Biol Psychiatry
1 Cereb Cortex
1 Int J Geriatr Psychiatry
1 Mol Psychiatry
1 Pharmacopsychiatry
2 Psychiatry Res
2 Psychol Med
11 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Psychiatr Scand

  1. SETIEN-SUERO E, Neergaard K, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, et al
    Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort.
    Acta Psychiatr Scand. 2019 Aug 5. doi: 10.1111/acps.13081.
    PubMed     Text format     Abstract available

    Biol Psychiatry

  2. CLARK SD, Abi-Dargham A
    The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence.
    Biol Psychiatry. 2019 May 22. pii: S0006-3223(19)31379.
    PubMed     Text format     Abstract available

    Cereb Cortex

  3. ROLLS ET, Cheng W, Gilson M, Gong W, et al
    Beyond the disconnectivity hypothesis of schizophrenia.
    Cereb Cortex. 2019 Aug 5. pii: 5543640. doi: 10.1093.
    PubMed     Text format     Abstract available

    Int J Geriatr Psychiatry

  4. OSTLING S, Backman K, Sigstrom R, Skoog I, et al
    Is the prevalence of psychosis in the very old decreasing? A comparison of 85-years-old born 22 years apart.
    Int J Geriatr Psychiatry. 2019 Aug 7. doi: 10.1002/gps.5192.
    PubMed     Text format     Abstract available

    Mol Psychiatry

  5. ZHU F, Guo R, Wang W, Ju Y, et al
    Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice.
    Mol Psychiatry. 2019 Aug 7. pii: 10.1038/s41380-019-0475.
    PubMed     Text format     Abstract available


  6. SCHAEFER M, Sarkar S, Theophil I, Leopold K, et al
    Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia.
    Pharmacopsychiatry. 2019 Aug 7. doi: 10.1055/a-0970-9310.
    PubMed     Text format     Abstract available

    Psychiatry Res

  7. DIAZ-FERNANDEZ S, Frias-Ortiz DF, Fernandez-Miranda JJ
    Suicide attempts in people with schizophrenia before and after participating in an intensive case managed community program: A 20-year follow-up.
    Psychiatry Res. 2019 Jul 10:112479. doi: 10.1016/j.psychres.2019.112479.
    PubMed     Text format     Abstract available

  8. GOINES KB, LoPilato AM, Addington J, Bearden CE, et al
    Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis.
    Psychiatry Res. 2019 Aug 3:112492. doi: 10.1016/j.psychres.2019.112492.
    PubMed     Text format     Abstract available

    Psychol Med

  9. LEI D, Pinaya WHL, van Amelsvoort T, Marcelis M, et al
    Detecting schizophrenia at the level of the individual: relative diagnostic value of whole-brain images, connectome-wide functional connectivity and graph-based metrics.
    Psychol Med. 2019 Aug 8:1-10. doi: 10.1017/S0033291719001934.
    PubMed     Text format     Abstract available

  10. MALL S, Platt JM, Temmingh H, Musenge E, et al
    The relationship between childhood trauma and schizophrenia in the Genomics of Schizophrenia in the Xhosa people (SAX) study in South Africa.
    Psychol Med. 2019 Aug 7:1-8. doi: 10.1017/S0033291719001703.
    PubMed     Text format     Abstract available

    Schizophr Res

  11. MEHTA UM, Basavaraju R, Thirthalli J
    Motor cortical reactivity to action observation: A biomarker to differentiate mania and schizophrenia?
    Schizophr Res. 2019 Aug 1. pii: S0920-9964(19)30324.
    PubMed     Text format    

  12. BJORNESTAD J, Davidson L, Ten Velden Hegelstad W, Stain H, et al
    Re-thinking social functioning in psychosis.
    Schizophr Res. 2019 Aug 2. pii: S0920-9964(19)30334.
    PubMed     Text format    

  13. ALCOVER KC, Oluwoye O, Kriegel L, McPherson S, et al
    Impact of first episode psychosis treatment on heavy cannabis use: Secondary analysis on RAISE-ETP study.
    Schizophr Res. 2019 Aug 2. pii: S0920-9964(19)30277.
    PubMed     Text format    

  14. TOPYUREK M, Tibbo P, Nunez C, Stephan-Otto C, et al
    Caffeine effects and schizophrenia: Is there a need for more research?
    Schizophr Res. 2019 Aug 2. pii: S0920-9964(19)30306.
    PubMed     Text format    

  15. SABE M, Sentissi O, Kaiser S
    Meditation-based mind-body therapies for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis.
    Schizophr Res. 2019 Aug 1. pii: S0920-9964(19)30310.
    PubMed     Text format     Abstract available

  16. SOMMER IE, Hugdahl K
    Auditory hallucinations in schizophrenia: Where are we now and where do we go from here? A personal commentary.
    Schizophr Res. 2019 Aug 2. pii: S0920-9964(19)30295.
    PubMed     Text format    

  17. OXENKRUG G, Bernstein HG, Guest PC, van der Hart M, et al
    Plasma xanthurenic acid in a context of insulin resistance and obesity in schizophrenia.
    Schizophr Res. 2019 Aug 2. pii: S0920-9964(19)30318.
    PubMed     Text format    

  18. LOPEZ-GARCIA P, Ashby S, Patel P, Pierce KM, et al
    Clinical and neurodevelopmental correlates of aggression in early psychosis.
    Schizophr Res. 2019 Aug 3. pii: S0920-9964(19)30325.
    PubMed     Text format     Abstract available

  19. GRATTAN RE, Linscott RJ
    Components of schizophrenia liability affect the growth of psychological stress sensitivity following major life events.
    Schizophr Res. 2019 Aug 3. pii: S0920-9964(19)30336.
    PubMed     Text format     Abstract available

  20. HESS JL, Tylee DS, Barve R, de Jong S, et al
    Transcriptomic abnormalities in peripheral blood in bipolar disorder, and discrimination of the major psychoses.
    Schizophr Res. 2019 Aug 4. pii: S0920-9964(19)30316.
    PubMed     Text format     Abstract available

  21. NGUYEN TT, Jeste DV
    Positive light on schizophrenia and aging: Commentary on course and predictors of symptomatic remission in schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment area, by Lange et al.
    Schizophr Res. 2019 Jul 31. pii: S0920-9964(19)30317.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.